Regenicin RGIN Stock
Regenicin Price Chart
Regenicin RGIN Financial and Trading Overview
| Regenicin stock price | 0.0050 USD |
| Previous Close | 0.0021 USD |
| Open | 0.0021 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.0021 - 0.0021 USD |
| 52 Week Range | 0.0001 - 0.01 USD |
| Volume | 6K USD |
| Avg. Volume | 4.56K USD |
| Market Cap | 322.31K USD |
| Beta (5Y Monthly) | -1.875 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.01 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
RGIN Valuation Measures
| Enterprise Value | -10893077 USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Regenicin Stock Price History
| Beta (5Y Monthly) | -1.875 |
| 52-Week Change | -16.0000029% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.01 USD |
| 52 Week Low | 0.0001 USD |
| 50-Day Moving Average | 0.001834 USD |
| 200-Day Moving Average | 0.001735 USD |
RGIN Share Statistics
| Avg. Volume (3 month) | 4.56K USD |
| Avg. Daily Volume (10-Days) | 7.42K USD |
| Shares Outstanding | 153.48M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | 18.15% |
| % Held by Institutions | 0.017% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 34:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | September 30, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | September 30, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -9.42% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -985391 USD |
| Diluted EPS (ttm) | -0.01 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 11.86M USD |
| Total Cash Per Share (mrq) | 0.08 USD |
| Total Debt (mrq) | 642.92K USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.656 |
| Book Value Per Share (mrq) | -0.04 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -700219 USD |
| Levered Free Cash Flow (ttm) | 12.18M USD |
Profile of Regenicin
| Country | United States |
| State | NJ |
| City | Little Falls |
| Address | 10 High Court |
| ZIP | 07424 |
| Phone | 973 557 8914 |
| Website | https://www.regenicin.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 3 |
Regenicin, Inc. focuses on developing and commercializing a technology of tissue-engineered skin substitutes. Its product portfolio includes NovaDerm, a multi-layered tissue-engineered living skin and cultured skin substitute product for the treatment of burns; and TempaDerm to treat smaller wound areas on patients, such as ulcers. The company products are used to restore the qualities of healthy human skin for use in the treatment of burns, chronic wounds, and various plastic surgery procedures. The company was formerly known as Windstar, Inc. and changed its name to Regenicin, Inc. in July 2010. Regenicin, Inc. was incorporated in 2007 and is headquartered in Little Falls, New Jersey.
Q&A For Regenicin Stock
What is a current RGIN stock price?
Regenicin RGIN stock price today per share is 0.0050 USD.
How to purchase Regenicin stock?
You can buy RGIN shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Regenicin?
The stock symbol or ticker of Regenicin is RGIN.
Which industry does the Regenicin company belong to?
The Regenicin industry is Biotechnology.
How many shares does Regenicin have in circulation?
The max supply of Regenicin shares is 153.48M.
What is Regenicin Price to Earnings Ratio (PE Ratio)?
Regenicin PE Ratio is now.
What was Regenicin earnings per share over the trailing 12 months (TTM)?
Regenicin EPS is -0.01 USD over the trailing 12 months.
Which sector does the Regenicin company belong to?
The Regenicin sector is Healthcare.